The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Changes to an Approved NDA or ANDA, Revision 1


Drug Information Branch (HFD-210), Center for Drug Evaluation and Research (CDER), 5600 Fishers Lane, Rockville, MD 20856, Tel. 301 827 4573, ,

Document Type:
FDA Guidance for Industry
This FDA guideline contains important information for changes.

Go back

GMP Conferences by Topics